ReviewInternational journal of molecular sciences2026
Extracellular Vesicle-Mediated Communication in Sellar Tumors: A Conceptual and Translational Framework.
Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sellar tumors, including pituitary neuroendocrine tumors (PitNETs), craniopharyngiomas, and rare malignant entities, represent a heterogeneous group of lesions characterized by complex interactions within the tumor microenvironment (TME). In recent years, extracellular vesicles (EVs) have emerged as key mediators of intercellular communication, playing a crucial role in tumor progression, invasion, and therapeutic resistance across multiple cancer types. Despite growing interest in EV biology, their role in sellar tumors remains poorly defined due to limited direct experimental evidence. This review provides a conceptual and translational framework for understanding EV-mediated communication in the context of sellar region tumors. We summarize current knowledge on EVs biogenesis, molecular cargo, and mechanisms of uptake, and discuss how these vesicles may influence tumor behavior through modulation of proliferation, angiogenesis, extracellular matrix (ECM) remodeling, and immune responses. Particular attention is given to PitNETs and craniopharyngiomas, integrating available evidence with insights derived from related tumor models. We further explore the potential of EVs as minimally invasive biomarkers and therapeutic tools and highlight the major technical and biological challenges that currently limit clinical translation. By identifying key knowledge gaps and future research directions, this review aims to guide further investigation into the role of EVs in sellar tumor biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.